Search Legislation

The Medicines (Control of Substances for Manufacture) Order 1971

What Version

 Help about what version
  • Latest available (Revised)
  • Original (As made)

Status:

This is the original version (as it was originally made). This item of legislation is currently only available in its original format. The electronic version of this UK Statutory Instrument has been contributed by Westlaw and is taken from the printed publication. Read more

Article 2(2) and Article 3

SCHEDULE 1

Column 1Column 2
Substances appearing to the Ministers to be substances which, as described in article 3 of this order, are not themselves medicinal products but which are used as ingredients in the manufacture of medicinal productsCircumstances in which the order applies to the substances referred to in Column 1
1. Amphotericin BWhen manufactured, assembled, sold, supplied, imported or exported for use as an ingredient in a medicinal product for parenteral injection into human beings or animals.
2. BacitracinWhen manufactured, assembled, sold, supplied, imported or exported for use as an ingredient in a medicinal product for parenteral injection into human beings or animals.
3. CapreomycinWhen manufactured, assembled, sold, supplied, imported or exported for use as an ingredient in a medicinal product for parenteral injection into human beings or animals.
4. ColistinWhen manufactured, assembled, sold, supplied, imported or exported for use as an ingredient in a medicinal product for parenteral injection into human beings or animals.
5. ErythromycinWhen manufactured, assembled, sold, supplied, imported or exported for use as an ingredient in a medicinal product for parenteral injection into human beings or animals.
6. GentamicinWhen manufactured, assembled, sold, supplied, imported or exported for use as an ingredient in a medicinal product for parenteral injection into human beings or animals.
7. HeparinWhen manufactured, assembled, sold, supplied, imported or exported for use as an ingredient in a medicinal product for parenteral injection into human beings or animals.
8. HyaluronidaseWhen manufactured, assembled, sold, supplied, imported or exported for use as an ingredient in a medicinal product for parenteral injection into human beings or animals.
9. KanamycinWhen manufactured, assembled, sold, supplied, imported or exported for use as an ingredient in a medicinal product for parenteral injection into human beings or animals.
10. NeomycinWhen manufactured, assembled, sold, supplied, imported or exported for use as an ingredient in a medicinal product for parenteral injection into human beings or animals.
11. PenicillinWhen manufactured, assembled, sold, supplied, imported or exported for use as an ingredient in a medicinal product for parenteral injection into human beings or animals.
12. Polymyxin BWhen manufactured, assembled, sold, supplied, imported or exported for use as an ingredient in a medicinal product for parenteral injection into human beings or animals.
13. Preparations of the pituitary (posterior lobe)When manufactured, assembled, sold, supplied, imported or exported for use as an ingredient in a medicinal product for parenteral injection into human beings or animals.
14. StreptomycinWhen manufactured, assembled, sold, supplied, imported or exported for use as an ingredient in a medicinal product for parenteral injection into human beings or animals.
15. The lincomycinsWhen manufactured, assembled, sold, supplied, imported or exported for use as an ingredient in a medicinal product for parenteral injection into human beings or animals.
16. The rifamycinsWhen manufactured, assembled, sold, supplied, imported or exported for use as an ingredient in a medicinal product for parenteral injection into human beings or animals.
17. The tetracyclinesWhen manufactured, assembled, sold, supplied, imported or exported for use as an ingredient in a medicinal product for parenteral injection into human beings or animals.
18. VancomycinWhen manufactured, assembled, sold, supplied, imported or exported for use as an ingredient in a medicinal product for parenteral injection into human beings or animals.
19. ViomycinWhen manufactured, assembled, sold, supplied, imported or exported for use as an ingredient in a medicinal product for parenteral injection into human beings or animals.
20. OxytetracyclineWhen manufactured, assembled, sold, supplied, imported or exported for use as an ingredient in a medicinal product which is to be administered to human beings or animals by means other than parenteral injection.
21. Tetracycline
Substances appearing to the Ministers to be substances which, as described in article 3 of this order, are not themselves medicinal products but which are used as ingredients in the manufacture of medicinal productsCircumstances in which the order applies to the substances referred to in Column 1
22. DextransWhen manufactured, assembled, sold, supplied, imported or exported for use as ingredients of dextran injections for human or animal use.
23. AntigensWhen manufactured, assembled, sold, supplied, imported or exported for use as an ingredient in a medicinal product for human or animal use.
24. AntiseraWhen manufactured, assembled, sold, supplied, imported or exported for use as an ingredient in a medicinal product for human or animal use.
25. AntitoxinsWhen manufactured, assembled, sold, supplied, imported or exported for use as an ingredient in a medicinal product for human or animal use.
26. Chorionic gonadotrophinWhen manufactured, assembled, sold, supplied, imported or exported for use as an ingredient in a medicinal product for human or animal use.
27. CorticotrophinWhen manufactured, assembled, sold, supplied, imported or exported for use as an ingredient in a medicinal product for human or animal use.
28. Follicle-stimulating hormoneWhen manufactured, assembled, sold, supplied, imported or exported for use as an ingredient in a medicinal product for human or animal use.
29. InsulinWhen manufactured, assembled, sold, supplied, imported or exported for use as an ingredient in a medicinal product for human or animal use.
30. SeraWhen manufactured, assembled, sold, supplied, imported or exported for use as an ingredient in a medicinal product for human or animal use.
31. StreptodornaseWhen manufactured, assembled, sold, supplied, imported or exported for use as an ingredient in a medicinal product for human or animal use.
32. StreptokinaseWhen manufactured, assembled, sold, supplied, imported or exported for use as an ingredient in a medicinal product for human or animal use.
33. ToxinsWhen manufactured, assembled, sold, supplied, imported or exported for use as an ingredient in a medicinal product for human or animal use.
34. VaccinesWhen manufactured, assembled, sold, supplied, imported or exported for use as an ingredient in a medicinal product for human or animal use.
35. Preparations of bloodWhen manufactured, assembled, sold, supplied, imported or exported for use as an ingredient in a medicinal product for human use.
36. PlasmaWhen manufactured, assembled, sold, supplied, imported or exported for use as an ingredient in a medicinal product for administration to animals.
37. Any substances wholly or partly derived from animals not being substances specifically mentioned in any of the above paragraphs of this column.

Back to top

Options/Help

Print Options

Close

Legislation is available in different versions:

Latest Available (revised):The latest available updated version of the legislation incorporating changes made by subsequent legislation and applied by our editorial team. Changes we have not yet applied to the text, can be found in the ‘Changes to Legislation’ area.

Original (As Enacted or Made):The original version of the legislation as it stood when it was enacted or made. No changes have been applied to the text.

Close

Opening Options

Different options to open legislation in order to view more content on screen at once

Close

More Resources

Access essential accompanying documents and information for this legislation item from this tab. Dependent on the legislation item being viewed this may include:

  • the original print PDF of the as enacted version that was used for the print copy
  • lists of changes made by and/or affecting this legislation item
  • confers power and blanket amendment details
  • all formats of all associated documents
  • correction slips
  • links to related legislation and further information resources
Close

More Resources

Use this menu to access essential accompanying documents and information for this legislation item. Dependent on the legislation item being viewed this may include:

  • the original print PDF of the as made version that was used for the print copy
  • correction slips

Click 'View More' or select 'More Resources' tab for additional information including:

  • lists of changes made by and/or affecting this legislation item
  • confers power and blanket amendment details
  • all formats of all associated documents
  • links to related legislation and further information resources